Gastroenterology CE Activities

Gastroenterology blog

View Details

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.
View Details

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.

RMEI Presentations

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

The Gastroenterology Learner Pathway in IBD: An Outcomes-Based Iterative Approach to IBD Education Using Advanced Analytics and Predictive Modeling to Sustain Behavioral Change

LATEST Gastroentrology ARTICLES

RSS feed: Latest Gastroentrology Articles Latest Gastroentrology Articles
  • Gene Therapy for Phenylketonuria in Adults October 29, 2026
    Eight adults with phenylketonuria received infusions of an adeno-associated virus serotype 8 vector carrying PAH cDNA.
    Huan Zhou, Xiaoli Li, Jiaxiang Ding, Hongtao Li, Yue Su, Jingjing Ye, Xiaoyue Li, Dongmei Cheng, Ying Wang, Yuzhou Ding, Jie Si, Lin Zhan, Yunqiu Xie, Yuanyuan Liu, Nan Han, Gang Wang, Yiting Liu, Guang Qu, Lixin Jiang, Jianping Weng
  • SLC6A19 Inhibitor Repinatrabit and Phenylalanine Levels in Phenylketonuria October 29, 2026
    In this phase 2 trial involving adults with phenylketonuria with baseline phenylalanine (Phe) levels above 600 μmol per liter, repinatrabit, a selective oral inhibitor of human SLC6A19, substantially decreased plasma Phe levels.
    Cary O. Harding, Nicola Longo, Markey McNutt, Rani H. Singh, Andreu Viader, George Vratsanos, Haoling H. Weng, Elaina Jurecki, Fernanda Leal-Pardinas, Wei Li, Guissou Dabiri, John P. Throup, Ania C. Muntau, for the JNT517-101 Trial Investigators Group*
  • An Element Out of Place October 29, 2026
    This interactive feature describes a 55-year-old woman who presented to the ED with a 10-day history of nausea, lightheadedness, and generalized abdominal pain. Test your diagnostic and therapeutic skills at NEJM.org.
    Suhas Gondi, David E. Velasquez, Andrew Allbee, J. Carl Pallais, Anand Vaidya, Bruce D. Levy

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Previously Published CE Activities